AGILE THERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Agile Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q2 2024.
  • Agile Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.75M, a 46.4% increase year-over-year.
  • Agile Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$13.6M, a 63.8% increase year-over-year.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2023 was -$19.9M, a 62.2% increase from 2022.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2022 was -$52.6M, a 26% increase from 2021.
  • Agile Therapeutics Inc annual Operating Income (Loss) for 2021 was -$71M, a 44.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$13.6M -$2.75M +$2.38M +46.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$15.9M -$2.76M +$3.95M +58.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$19.9M -$4.05M +$2.83M +41.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$22.7M -$4M +$14.7M +78.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$37.4M -$5.13M +$6.27M +55% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$43.7M -$6.71M +$8.87M +56.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$52.6M -$6.88M +$15.5M +69.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$68M -$18.7M -$2.93M -18.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$65.1M -$11.4M +$5.25M +31.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$70.4M -$15.6M +$649K +4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$71M -$22.4M -$5.62M -33.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-28
Q3 2021 -$65.4M -$15.8M -$1.12M -7.63% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$64.3M -$16.7M -$6.61M -65.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$57.7M -$16.2M -$8.61M -113% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$49.1M -$16.7M -$10.6M -174% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$38.4M -$14.7M -$10.2M -226% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-30
Q2 2020 -$28.3M -$10M -$6.49M -183% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-26
Q1 2020 -$21.8M -$7.62M -$2.91M -61.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$18.9M -$6.11M -$2.38M -63.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-30
Q3 2019 -$16.5M -$4.5M -$884K -24.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$15.6M -$3.55M +$1.6M +31.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$17.2M -$4.71M +$2.34M +33.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$19.5M -$3.73M +$2.26M +37.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$21.8M -$3.62M +$3.09M +46.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 -$24.9M -$5.15M +$1.85M +26.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$26.7M -$7.05M +$80K +1.12% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 -$26.8M -$5.99M +$1.82M +23.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-20
Q3 2017 -$28.6M -$6.7M +$390K +5.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$29M -$7M +$845K +10.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$29.9M -$7.13M -$146K -2.09% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$29.7M -$7.81M +$1.36M +14.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 -$31.1M -$7.09M +$1.87M +20.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$33M -$7.84M +$140K +1.75% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 -$33.1M -$6.98M -$3K -0.04% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$33.1M -$9.17M -$2.64M -40.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$30.4M -$8.97M -$2.92M -48.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$27.5M -$7.98M -$4.49M -128% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$23M -$6.98M -$4.53M -185% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$18.5M -$6.52M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$6.05M -$2.73M -82.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$3.49M -$246K -7.56% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$2.45M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q3 2013 -$3.32M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$3.25M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.